Breaking News

Kincell Bio Advances Moonlight Bio’s T Cell Candidate

Kincell will provide GMP manufacturing services to support the scale-up and clinical supply of Moonlight’s lead T cell therapy product.

By: Rachel Klemovitch

Assistant Editor

Kincell Bio, a US cell therapy CDMO, entered a partnership with Moonlight Bio, Inc., a Seattle-based biotech company pioneering advanced T cell therapies for solid tumors. In this partnership, Kincell provides CMC development and GMP manufacturing services to advance Moonlight’s lead T cell therapy program into clinical trials. Kincell is providing process and analytical transfer, and GMP manufacturing services, to support the scale-up and clinical supply of Moonlight’s lead T cell therapy pr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters